scispace - formally typeset
Open AccessJournal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

TLDR
Authors/Task Force Members (François Macha, Colin Baigentb,∗∗,2, Alberico L. Catapanoc), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Patelcl)
About
This article is published in Atherosclerosis.The article was published on 2019-09-02 and is currently open access. It has received 2972 citations till now. The article focuses on the topics: Lipid modification & Very low-density lipoprotein.

read more

Citations
More filters

Standards of Medical Care in Diabetes

TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren, +105 more
Journal Article

Effects of the amount and intensity of exercise on plasma lipoproteins: Editor's comments

TL;DR: The highest amount of weekly exercise, with minimal weight change, had widespread beneficial effects on the lipoprotein profile, seen most clearly with the high amount of high-intensity exercise.
Journal ArticleDOI

Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis

TL;DR: Atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis.
References
More filters
Journal ArticleDOI

The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease, and II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering

TL;DR: The LRC-CPPT findings show that reducing total cholesterol by lowering LDL-C levels can diminish the incidence of CHD morbidity and mortality in men at high risk for CHD because of raised cholesterol levels.
Journal ArticleDOI

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

TL;DR: The risk of mortality from ischaemic heart disease is exceptionally high in young adult women with Type 1 diabetes, with rates similar to those in men with Type 2 diabetes under the age of 40, and the need to identify and treat coronary risk factors in these young patients is emphasised.
Journal ArticleDOI

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

Angela M. Wood, +132 more
- 14 Apr 2018 - 
TL;DR: Current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week, and data support limits for alcohol consumption that are lower than those recommended in most current guidelines.
Journal ArticleDOI

Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention

TL;DR: This advisory focuses primarily onLinoleic acid, an 18-carbon fatty acid with 2 double bonds, which accounts for 85% to 90% of the dietary omega-6 PUFA, recognizing that dietary AA, which can affect tissue AA levels,5 may have physiological sequelae.
Journal ArticleDOI

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

TL;DR: Intensive lipid lowering with high-dose statin therapy provides a significant benefit over standard-dose therapy for preventing predominantly non-fatal cardiovascular events.
Related Papers (5)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more